In addition, mutations in NPM1 have been identified in AML patients and are associated with favorable prognosis for patients without cytogenetic alterations although the impact of such mutation on nucleolar functions of NPM1 remain to be investigated [1,2,6,14]. This evidence concerns the gene NPM1 and acute myeloid leukemia.